Article

HGGT: Heterogeneous Gated Graph Transformer for Predicting Clinical Trial Success

2026-07-01

Abstract excerpt

Clinical trials are critical milestones in the drug development pipeline, yet their high failure rates and substantial costs underscore the need for robust predictive models. This study introduces a Heterogeneous Gated Graph Transformer (HGGT) model tailored to predict clinical trial success. Unlike existing methods that typically model trial-related entities in isolation or with homogeneous graphs, HGGT explicitl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1d81148f-eab6-5dd5-817b-7de393fa6aff
DOI: 10.64898/2026.06.28.26356795

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

HGGT: Heterogeneous Gated Graph Transformer for Predicting Clinical Trial SuccessDOI 10.64898/2026.06.28.26356795Read

NetMedGPT - A network medicine foundation model for extensive disease mechanism mining and drug repurposingSemantic proximity Read

ECLIPSE: Exploration of Complex Ligand-Protein Interactions through Learning from Systems-level Heterogeneous Biomedical Knowledge GraphsSemantic proximity Read

BEACON: predicting side effects and therapeutics outcomes to drugs by Bridging knowlEdge grAph with CONtextual language modelSemantic proximity Read

Emden: A novel method integrating graph and transformer representations for predicting the effect of mutations on clinical drug response.Semantic proximity Read

<i>MedGraphNet</i> : Leveraging Multi-Relational Graph Neural Networks and Text Knowledge for Biomedical PredictionsSemantic proximity Read

Drug repurposing for rare diseases via a gene-bridged heterogeneous knowledge graph and graph attention networkSemantic proximity Read

Constructing a Finer-Grained Representation of Clinical Trial Results from ClinicalTrials.govSemantic proximity Read

Phenome-wide identification of therapeutic genetic targets, leveraging knowledge graphs, graph neural networks, and UK Biobank data.Semantic proximity Read

Encoding Drug-Target-Pathway-Disease profiles for Drug-Cancer Association Prediction using Graph Transformer-Convolution NetworksSemantic proximity Read

Artemis: Harnessing Knowledge Graphs for Next-Generation Drug Target PrioritizationSemantic proximity Read

Multi-layer guilt-by-association-based drug repurposing by integrating clinical knowledge on biological heterogeneous networksSemantic proximity Read

CellAwareGNN: Single-Cell Enhanced Knowledge Graph Foundation Model for Drug Indication PredictionSemantic proximity Read